Task: Answer the multiple-choice question.
Query: Which drug exhibits a -8.294\% hERG inhibition at 1uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a.) Cc1cccc(OCC(O)Cn2c(=N)n(CCN3CCOCC3)c3ccccc32)c1.Cl
b.) COc1ccccc1NS(=O)(=O)c1cc(NC(=O)Nc2cccc(C)c2)ccc1N1CCCCC1
Answer: a. Cc1cccc(OCC(O)Cn2c(=N)n(CCN3CCOCC3)c3ccccc32)c1.Cl
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1cccc(OCC(O)Cn2c(=N)n(CCN3CCOCC3)c3ccccc32)c1.Cl
Cc1cccc(OCC(O)Cn2c(=N)n(CCN3CCOCC3)c3ccccc32)c1.Cl
1-[2-imino-3-(2-morpholin-4-ylethyl)benzimidazol-1-yl]-3-(3-methylphenoxy)propan-2-ol;hydrochloride